Print RSS

Eastland Medical Systems
Eastland Medical Systems is a publicly listed Company on the Australian Securities Exchange (ASX:EMS) that is involved in the commercialisation of low-risk pharmaceutical projects.

The Company’s key project is ArTiMist™, a malaria treatment developed specifically for children with severe malaria. 


ArTiMist has the potential to save countless young lives throughout third world and underprivileged regions.

Growth Strategy
Eastland is committed to developing its pharmaceutical business model by expanding its product portfolio with products that demonstrate major cost, functional and effectual advantages over competitors, thereby securing on-going consumer demand.

Announcements News & Media Releases
1.    11-09-29 ArTiMist™ listed as one of the 5 most promising drugs in Phase III trials  11-09-29 ArTiMist™ listed as one of the 5 most promising drugs in Phase III trials (11 KB)
2.    11-09-23 Eastland Raises $226,000 on Priority Entitlement Offer  11-09-23 Eastland Raises $226,000 on Priority Entitlement Offer (68 KB)
3.    11-07-11 Boardroom Radio Broadcast  11-07-11 Boardroom Radio Broadcast (76 KB)
4.    11-07-06 SHAREHOLDER UPDATE - JULY 2011  11-07-06 SHAREHOLDER UPDATE - JULY 2011 (95 KB)
5.    11-05-31 The Lancet article "From quinine to artesunate in Africa"  11-05-31 The Lancet article "From quinine to artesunate in Africa" (281 KB)
6.    11-05-31 Eastland Clinical Trial Update May 2011  11-05-31 Eastland Clinical Trial Update May 2011 (129 KB)
7.    11-04-28 Clinical Trial Update  11-04-28 Clinical Trial Update (150 KB)
8.    11-04-12 Eastland raises $4.2 Milion on Placement & Share Purchase Plan  11-04-12 Eastland raises $4.2 Milion on Placement & Share Purchase Plan (155 KB)
9.    11-04-06 AFR article April 5, 2011  11-04-06 AFR article April 5, 2011 (3335 KB)
10.    11-04-05 Update on Eastland's subsidiary Westcoast Surgical & Medical Supplies  11-04-05 Update on Eastland's subsidiary Westcoast Surgical & Medical Supplies (214 KB)
11.    11-03-29 EMS Presentation  11-03-29 EMS Presentation (3608 KB)
12.    11-03-28 SPP EXTENSION  11-03-28 SPP EXTENSION (69 KB)
13.    11-03-17 BOARDROOM RADIO BROADCAST  11-03-17 BOARDROOM RADIO BROADCAST (145 KB)
14.    11-03-08 Share purchase Plan Offer  11-03-08 Share purchase Plan Offer (841 KB)
15.    11-03-03 UPDATE  11-03-03 UPDATE (234 KB)
16.    11-03-01 Half Yearly Report and Accounts  11-03-01 Half Yearly Report and Accounts (1565 KB)
17.    11-02-02 Eastland’s subsidiary wins first tender valued at $2.5m  11-02-02 Eastland’s subsidiary wins first tender valued at $2.5m (586 KB)
18.    11-02-01 Change of Director`s Interest Notice  11-02-01 Change of Director`s Interest Notice (171 KB)
19.    11-01-10 Westcoast Surgical and Medical Supplies  11-01-10 Westcoast Surgical and Medical Supplies (589 KB)
20.    11-01-04 Director's clarification on share sale  11-01-04 Director's clarification on share sale (578 KB)
21.    10-11-25 Patient study findings are very positive for ARTIMIST  10-11-25 Patient study findings are very positive for ARTIMIST (608 KB)
22.    10-11-18 Response to ASX query  10-11-18 Response to ASX query (77 KB)
23.    10-11-23 MALARIA TRIAL - PATIENT DOSING COMMENCED  10-11-23 MALARIA TRIAL - PATIENT DOSING COMMENCED (598 KB)
24.    10-10-28 Notice of Annual General Meeting  10-10-28 Notice of Annual General Meeting (172 KB)
25.    10-10-27 Management and Board Restructure  10-10-27 Management and Board Restructure (567 KB)
26.    10-09-30 Eastland accepts unconditional offer for its Portand property  10-09-30 Eastland accepts unconditional offer for its Portand property (556 KB)
27.    10-09-21 Clinican Trial Results Presented at ICAAC in Boston USA  10-09-21 Clinican Trial Results Presented at ICAAC in Boston USA (3091 KB)
28.    10-08-09 SUCCESSFUL PLACEMENT  10-08-09 SUCCESSFUL PLACEMENT (555 KB)
29.    10-07-09 CALVIN ROSS  10-07-09 CALVIN ROSS (890 KB)
30.    10-07-22 BOARDROOM INTERVIEW  10-07-22 BOARDROOM INTERVIEW (554 KB)
31.    10-07-21 Consultant Appointment  10-07-21 Consultant Appointment (560 KB)
32.    10-07-06 Response to ASX Query  10-07-06 Response to ASX Query (2696 KB)
33.    10-07-05 Eastland to present at the 2010 Interscience Conference  10-07-05 Eastland to present at the 2010 Interscience Conference (600 KB)
34.    10-06-11 Event Impact - Industrial Research  10-06-11 Event Impact - Industrial Research (529 KB)
35.    10-06-11 ASX Release - Update on HC Berlin Pharna AG and Clinical Trials  10-06-11 ASX Release - Update on HC Berlin Pharna AG and Clinical Trials (609 KB)
36.    10-05-19 ASX Release No 454 Research Report - ArtiMist  10-05-19 ASX Release No 454 Research Report - ArtiMist (755 KB)
37.    10-04-28 New Treatment to Reduce Deaths in Children with Malaria  10-04-28 New Treatment to Reduce Deaths in Children with Malaria (605 KB)
38.    10-04-28 ArTiMist™ Study Highly Successfull in Treating Children With Severe Malaria  10-04-28 ArTiMist™ Study Highly Successfull in Treating Children With Severe Malaria (623 KB)
more>>
Broker Research
1.    11-03-08 Event impact Patersons  11-03-08 Event impact Patersons (453 KB)
2.    11-03-04 Event Impact Patersons  11-03-04 Event Impact Patersons (442 KB)
3.    10-11-26 Significant implications for ArTiMist from IV Artesunate trial. SPEC BUY  10-11-26 Significant implications for ArTiMist from IV Artesunate trial. SPEC BUY (433 KB)
4.    10-10-28 Event Impact - Patersons  10-10-28 Event Impact - Patersons (384 KB)
5.    10-08-09 UPDATE RESEARCH REPORT  10-08-09 UPDATE RESEARCH REPORT (431 KB)
6.    10-07-06 Event Impact - Patersons Securities  10-07-06 Event Impact - Patersons Securities (548 KB)
7.    10-06-11 Event Impact - Industrial Research  10-06-11 Event Impact - Industrial Research (529 KB)
8.    10-05-19 ArtiMist - The Next Front-Line Drug for Severe Malaria  10-05-19 ArtiMist - The Next Front-Line Drug for Severe Malaria (585 KB)
9.    10-04-29 Event Impact - Industrial Research  10-04-29 Event Impact - Industrial Research (523 KB)
more>>
Roll Back Malaria


Malaria in the News